Techno Trends
Worldwide advancements and breakthroughs in pharmaceutical products and technology are thoroughly covered by Techno Trends. You may stay up to date with all the most recent pharmaceutical developments (product news and technological trends) taking place throughout the world.
Eli Lilly Launch New Drug to Treat Acute Migraine in Adults
A new oral medication, REYVOW™ (lasmiditan) has been launched by Eli Lilly and Company for the treatment of acute migraine, with or without aura, in adults....
New Oral Inhibitor Launched to Treat Patients with Histiocytic Neoplasms
A new oral inhibitor, cobimetinib (Cotellic) has been launched by the Memorial Sloan Kettering Cancer Center (MSK) for the treatment of adult patients with histolytic neoplasms (HN) (Erdheim-Chester Disease, Rosai-Dorfman, Langerhans Histiocytosis)....
Janssen Pharma’s Niraparib Treats Patients with Prostate Cancer
The PARP inhibitor is used to treat patients with BRCA 1/2 gene-mutated metastatic castration-resistant prostate cancer (mCRPC) and DNA repair gene defects (DRD). The BRCA 1/2 mutations are the most common DRD in patients with mCRPC....
UC Santa Cruz Researchers Develop Novel Nanoprobes
A new ultrasensitive nanoscale optical probe has been developed by the researchers at UC Santa Cruz that can monitor the bioelectric activity of neurons and other excitable cells....
Boehringer Ingelheim Launches Breakthrough Medication for Treatment of ILDs
A new medication, Ofev® (nintedanib) has been launched by Boehringer Ingelheim for the treatment of patients with chronic fibrosing Interstitial Lung Diseases (ILDs) with a progressive phenotype....
Roche's New Lymphoma Medicine to Treat Lupus Nephritis
Genentech, a member of the Roche Group, has introduced a groundbreaking medicine called Gazyva® (obinutuzumab) for the treatment of lupus nephritis in adults....
Breakthrough Drug Launched to Treat Desmoid Tumors in Adult Patients
SpringWorks Therapeutics has introduced an experimental drug called nirogacestat for the treatment of rare and progressive cancer called desmoid tumors in adult patients....
Janssen Launches RSV Vaccine to Treat Older Patients
An investigational prophylactic vaccine has been launched by the Janssen Pharmaceutical Companies of Johnson & Johnson (Janssen) for the prevention of respiratory syncytial virus (RSV)...
Aeglea BioTherapeutics Launches Investigational Therapy for Treatment of ARG1-D
Aeglea BioTherapeutics has launched Pegzilarginase, an investigational therapy designed to address Arginase 1 Deficiency (ARG1-D), a rare genetic disorder...
UNC Lineberger Researchers Discover Experimental Compound to Block Lymphoma
Researchers at the UNC Lineberger Comprehensive Cancer Center at the University of North Carolina have made a significant discovery regarding primary effusion lymphoma, a highly aggressive form of non-Hodgkin lymphoma....
